Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pemetrexed
Sponsor: Eli Lilly and Company